GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » QSAM Biosciences Inc (OTCPK:QSAM) » Definitions » Cyclically Adjusted PB Ratio

QSAM Biosciences (QSAM Biosciences) Cyclically Adjusted PB Ratio : (As of Jun. 01, 2024)


View and export this data going back to 2011. Start your Free Trial

What is QSAM Biosciences Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


QSAM Biosciences Cyclically Adjusted PB Ratio Historical Data

The historical data trend for QSAM Biosciences's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QSAM Biosciences Cyclically Adjusted PB Ratio Chart

QSAM Biosciences Annual Data
Trend Mar14 Mar15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

QSAM Biosciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of QSAM Biosciences's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, QSAM Biosciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QSAM Biosciences's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, QSAM Biosciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where QSAM Biosciences's Cyclically Adjusted PB Ratio falls into.



QSAM Biosciences Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

QSAM Biosciences's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, QSAM Biosciences's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.045/129.4194*129.4194
=0.045

Current CPI (Dec. 2023) = 129.4194.

QSAM Biosciences Quarterly Data

Book Value per Share CPI Adj_Book
201403 -204.094 99.695 -264.947
201406 -273.684 100.560 -352.229
201409 -337.705 100.428 -435.194
201412 -334.973 99.070 -437.591
201503 -365.217 99.621 -474.459
201506 -647.283 100.684 -832.020
201509 -778.804 100.392 -1,003.993
201512 -95.605 99.792 -123.989
201603 -117.365 100.470 -151.182
201606 -82.107 101.688 -104.498
201609 -74.281 101.861 -94.378
201612 -74.368 101.863 -94.487
201703 -44.614 102.862 -56.133
201706 -50.227 103.349 -62.897
201709 -54.213 104.136 -67.376
201712 -81.067 104.011 -100.870
201803 -78.111 105.290 -96.012
201806 -84.918 106.317 -103.371
201809 -93.365 106.507 -113.451
201812 -76.365 105.998 -93.239
201903 -84.019 107.251 -101.386
201906 -99.827 108.070 -119.549
201909 -91.558 108.329 -109.383
201912 -87.962 108.420 -104.999
202003 -87.263 108.902 -103.704
202006 -102.298 108.767 -121.722
202009 -16.044 109.815 -18.908
202012 -10.375 109.897 -12.218
202103 1.184 111.754 1.371
202106 0.563 114.631 0.636
202109 0.117 115.734 0.131
202112 -0.252 117.630 -0.277
202203 -0.972 121.301 -1.037
202206 -1.505 125.017 -1.558
202209 -1.255 125.227 -1.297
202212 -0.849 125.222 -0.877
202303 -0.254 127.348 -0.258
202306 -0.509 128.729 -0.512
202309 -0.531 129.860 -0.529
202312 0.045 129.419 0.045

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


QSAM Biosciences  (OTCPK:QSAM) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


QSAM Biosciences Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of QSAM Biosciences's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


QSAM Biosciences (QSAM Biosciences) Business Description

Traded in Other Exchanges
N/A
Address
9442 Capital of Texas Highway North, Plaza 1, Suite 500, Austin, TX, USA, 78759
QSAM Biosciences Inc is a clinical-stage novel radiopharmaceutical company. The company is developing treatments for bone cancer and related diseases.
Executives
Adam King officer: Chief Financial Officer 9442 CAPITAL OF TEXAS HWY N, PLAZA 1, SUITE 500, AUSTIN TX 78759
Link Jr. Charles J director C/O NEWLINK GENETICS CORP., 2503 SOUTH LOOP DR., SUITE 5100, AIMES IA 50010
Adriann Sax director 7 DORSET COURT,, EAST BRUNSWICK, NJ 08816
David Charles Link director 2100 E 54TH STREET NORTH, SIOUX FALLS SD 57104
Douglas R Baum director, officer: CEO & Director 5000 RAFFEE COVE, AUSTIN TX 78731-1132
C Richard Piazza director, officer: Executive Chairman 2236 EAST MALL, SUITE 208, UNIVERSITY OF BRITISH COLUMBIA, VANCOUVER A1 V6T 1Z3
Checkmate Strategic Capital Holdings, Llc other: Member of 13(d) 10% owner grp 595 E. COLORADO BOULEVARD, SUITE 530, PASADENA CA 91101
Checkmate Strategic Capital 2, Llc 10 percent owner, other: See Explanation of Responses 595 E. COLORADO BOULEVARD, SUITE 530, PASADENA CA 91101
Checkmate Capital Group, Llc 10 percent owner, other: Member of 13(d) 10% owner grp 595 E. COLORADO BOULEVARD, SUITE 530, PASADENA CA 91101
Charles Thomas Paschall other: Member of 13(d) 10% owner grp 595 E. COLORADO BOULEVARD, SUITE 530, PASADENA CA 91101
Christopher M. Nelson director, officer: General Counsel 420 ROYAL PALM WAY, SUITE #100, PALM BEACH FL 33480
Scott W. Whitney director, other: Former Director 96 WINDSOR DRIVE, PINE BROOK NJ 07058
Kevin Bolin director, officer: Former Chairman & CEO 1081 ROSEDALE DRIVE, ATLANTA GA 30306
Tristan Peitz director, other: Former Director C/O Q2POWER TECHNOLOGIES, INC., 420 ROYAL PALM WAY, #100, PALM BEACH FL 33480
Joel David Mayersohn director 350 EAST LAS OLAS BLVD. #1150, FORT LAUDERDALE FL 33301

QSAM Biosciences (QSAM Biosciences) Headlines

From GuruFocus

QSAM Biosciences Provides 2022 Update and 2023 Milestones to Shareholders

By Stock market mentor Stock market mentor 01-10-2023

QSAM Biosciences Appoints Adriann Sax to Board of Directors

By GuruFocusNews GuruFocusNews 01-25-2022